gastrointestinal discomfort
Once updated use patterns reflecting this policy are available to calculate rates, we will use all relevant products and the combined product utilization patterns (OPPS and non-facility) to determine a weighted average per-unit cost by category to set separate payment rates for each of the three categories, and we will continue to monitor this product class and propose additional adjustments to the policy as necessary in future rulemaking
People with PCOS, thyroid disorders, or other hormonal conditions These conditions affect metabolism and weight regulation independently of GLP-1 medication
Klein, MD/PhD, Addiction Medicine, Caron Treatment Centers The second wave, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), reached the public eye through landmark weight loss data published in the New England Journal of Medicine